The role of β‐barrels 1 and 2 in the enzymatic activity of factor XIII A‐subunit
ISTH Academy, Helen Philippou, 226175
A re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH
ISTH Academy, Hideo Wada, 226176
Role of von Willebrand factor and ADAMTS‐13 in early brain injury after experimental subarachnoid hemorrhage
ISTH Academy, Mervyn Vergouwen, 226177
Correction of a dominant‐negative von Willebrand factor multimerization defect by small interfering RNA‐mediated allele‐specific inhibition of mutant von Willebrand factor
ISTH Academy, Jeroen Eikenboom, 226179
Extended International Normalized Ratio testing intervals for warfarin‐treated patients
ISTH Academy, Geoffrey Barnes, 226180
Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti‐idiotype monoclonal antibodies
ISTH Academy, Keiji Nogamimi, 226181
A new redox switch regulating von Willebrand factor activity
ISTH Academy, Renhao Li, 226182
Flow cytometric analysis of extracellular vesicle subsets in plasma: impact of swarm by particles of non‐interest
ISTH Academy, Sten Libregts, 226183
A systematic review and Bayesian network meta‐analysis of risk of intracranial hemorrhage with direct oral anticoagulants
ISTH Academy, Zachary Wolfe, 226184
Impact of time since diagnosis and mortality rate on cancer‐associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort
ISTH Academy, Sigrid Braekkan, 226185
Four times cancer
ISTH Academy, Session Speakers, 226186
Stay Coagulated and Join the ISTH Today
ISTH Academy, Session Speakers, 226187
Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia
ISTH Academy, Ishac Nazi, 226188
Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: reply
ISTH Academy, Sarah Takach Lapner, 226189
Questioning the use of an age‐adjusted D‐dimer threshold to exclude venous thromboembolism: comment
ISTH Academy, Noémie Kraaijpoel, 226190
Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey: comment
ISTH Academy, Ole H. Olsen, 226191
Issue Information
ISTH Academy, Session Speakers, 226192
Risk stratification for the development of venous thromboembolism in hospitalized patients with cancer
ISTH Academy, Cynthia Wu, 226193
Reduced‐dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta‐analysis
ISTH Academy, Lakshman Vasanthamohan, 226194
Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study
ISTH Academy, Theodore Spiro, 226195
A comparative analysis of different automated von Willebrand factor glycoprotein Ib‐binding activity assays in well typed von Willebrand disease patients
ISTH Academy, Inge Vangenechten, 226196
Hemostasis biomarkers and incident cognitive impairment: the REGARDS study
ISTH Academy, Mary Cushman, 226197
Prediction of short‐term prognosis in elderly patients with acute pulmonary embolism: validation of the RIETE score
ISTH Academy, Tobias Tritschler, 226198
What the neighbors say
ISTH Academy, Session Speakers, 226199
Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH
ISTH Academy, Margaret Ragni, 226200
Subtype‐specific clinical and prognostic relevance of tumor‐expressed F5 and regulatory F5 variants in breast cancer: the CoCaV study
ISTH Academy, Mari Tinholt, 226201
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta‐analysis
ISTH Academy, Marcello Di Nisio, 226202
Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey: reply
ISTH Academy, Teguh Widjajadi, 226203
Preventing Post-Thrombotic Syndrome
ISTH Academy, Susan Kahn & Akhilesh Sista, 210957
Hemostasis: Emerging Therapies
ISTH Academy, Jim Munn & Kate Khair, 219028
Karl Landsteiner
ISTH Academy, Session Speakers, 219349
Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe hemorrhage
ISTH Academy, Michael Desborough, 219350
Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation
ISTH Academy, Frank Coumans, 219351
Platelets loaded with liposome‐encapsulated thrombin have increased coagulability
ISTH Academy, Christian J. Kastrup, 219352
Extracellular vesicles from human saliva promote hemostasis by delivering coagulant tissue factor to activated platelets
ISTH Academy, Yuanjie Yu, 219353
Use of direct oral anticoagulants in antiphospholipid syndrome
ISTH Academy, Hannah Cohen, 219354
Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelor
ISTH Academy, Beate Kehrel, 219355
Issue Information
ISTH Academy, Session Speakers, 219356
Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism
ISTH Academy, Cihan Ay, 219357
Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study
ISTH Academy, Pieter W. Kamphuisen, 219358
Bacterial killing by platelets: making sense of (H)IT
ISTH Academy, Marc F. Hoylaerts, 219359
Recombinant factor XIII A‐subunit in a patient with factor XIII deficiency and recurrent pregnancy loss
ISTH Academy, Murtadha Al‐Khabori, 219360
Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism
ISTH Academy, Frederikus Klok, 219361
Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti‐factor IXa/factor X bispecific antibody emicizumab
ISTH Academy, Keiji Nogamimi, 219362
Effect of rosuvastatin on risk markers for venous thromboembolism in cancer
ISTH Academy, Steven Ades, 219363
Outcomes following a negative computed tomography pulmonary angiography according to pulmonary embolism prevalence: a meta‐analysis of the management outcome studies
ISTH Academy, Steve Provencher, 219364
Factor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review
ISTH Academy, Johanna van der Bom, 219365
Stabilization of warfarin‐binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition
ISTH Academy, Weikai Li, 219366
Novel assay demonstrates that coronary artery disease patients have heightened procoagulant platelet response
ISTH Academy, Vivien Chen, 219367
What the neighbor says
ISTH Academy, Session Speakers, 219368
Professor Gustav Victor Rudolph Born (29 July 1921 – 16 April 2018)
ISTH Academy, Session Speakers, 219369
Comparative analysis of marketed factor VIII products: recombinant products are not alike vis‐a‐vis soluble protein aggregates and subvisible particles
ISTH Academy, Julia Anzengruber, 219370
PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway
ISTH Academy, Matthew Rondina, 219371
Preclinical pharmacokinetics and biodistribution of subcutaneously administered glycoPEGylated recombinant factor VIII (N8‐GP) and development of a human pharmacokinetic prediction model
ISTH Academy, Frederik Rode, 219372
Management of cancer‐associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH
ISTH Academy, Correspondence |Dr. Marc Carrier, 219373
Stay Coagulated and Join the ISTH Today
ISTH Academy, Session Speakers, 219374
Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA
ISTH Academy, Andreas Greinacher, 219375
Mechanisms of enhanced thrombin‐generating capacity in patients with cirrhosis
ISTH Academy, Ton Lisman, 219376
Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis
ISTH Academy, Thomas Sinegre, 219377
Staphylococcus aureus‐induced complement activation promotes tissue factor‐mediated coagulation
ISTH Academy, Tom Eirik Mollnes, 219451
Risk of early‐onset breast cancer among women exposed to thoracic computed tomography in pregnancy or early postpartum
ISTH Academy, Joel G. Ray, 219452
Age‐adjusted D‐dimer cut‐off leads to more efficient diagnosis of venous thromboembolism in the emergency department: a comparison of four assays
ISTH Academy, Maria Farm, 219453
Retinoic acid receptor‐α regulates synthetic events in human platelets: reply
ISTH Academy, Hansjorg Schwertz, 219454
Platelet packing density is an independent regulator of the hemostatic response to injury
ISTH Academy, Maurizio Tomaiuolo, 219455
Sex‐specific performance of pre‐imaging diagnostic algorithms for pulmonary embolism
ISTH Academy, Thijs Van Mens, 219456
Basic weapons to degrade C3a and C5a
ISTH Academy, Jonathan H. Foley, 219457
Acute coronary syndrome remodels the antiplatelet aggregation properties of HDL particle subclasses
ISTH Academy, Cecile Vindis, 219458
Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations: comment
ISTH Academy, Raphaël Marlu, 219459
What a drag: necrotic platelets induce remote neutrophil thrombi following ischemic gut injury
ISTH Academy, Kimberly Martinod, 219460
Stay Coagulated and Join the ISTH Today
ISTH Academy, Session Speakers, 219461
Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC‐2/podoplanin‐dependent platelet aggregation and lung metastasis
ISTH Academy, Katsue Suzuki-Inoue, 219462
Factor Xa and VIIa inhibition by tissue factor pathway inhibitor is prevented by a monoclonal antibody to its Kunitz‐1 domain
ISTH Academy, Helle Petersen, 219463
Carboxypeptidase B2 and N play different roles in regulation of activated complements C3a and C5a in mice
ISTH Academy, John Morser, 219464
Retinoic acid receptor‐α regulates synthetic events in human platelets: comment
ISTH Academy, Henri de la Salle, 219465
Vasomotor symptoms and the risk of incident venous thrombosis in postmenopausal women
ISTH Academy, Laura B. Harrington, 219466
What the neighbors say
ISTH Academy, Session Speakers, 219467
Efficacy, safety and pharmacokinetics of a new high‐purity factor X concentrate in women and girls with hereditary factor X deficiency
ISTH Academy, Miranda Norton, 219468
Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants
ISTH Academy, Sophie Testa, 219469
The chaperone protein HSP47: a platelet collagen binding protein that contributes to thrombosis and hemostasis
ISTH Academy, Parvathy Sasikumar, 219470
Lots and lots of women
ISTH Academy, Session Speakers, 219471
An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH
ISTH Academy, Marlien Pieters, 219472
An international collaborative study to calibrate the WHO 2nd International Standard for Ancrod (15/106) and the WHO Reference Reagent for Batroxobin (15/140): communication from the SSC of the ISTH
ISTH Academy, Craig Thelwell, 219473
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation
ISTH Academy, Cecilia Becattini, 219474
Issue Information
ISTH Academy, Session Speakers, 219475
The plasminogen receptor Plg‐R is essential for mammary lobuloalveolar development and lactation
ISTH Academy, R. J. Parmer, 219476
Platelet function testing: dead or alive
ISTH Academy, Amin Polzin, 219477
Auto‐ and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences
ISTH Academy, Laszlo Muszbek, 219478
Glycoprotein VI in securing vascular integrity in inflamed vessels
ISTH Academy, Benoit Ho-Tin-Noé, 219323
Fibrinogen concentrations predict long‐term cognitive outcome in young ischemic stroke patients
ISTH Academy, Annie Pedersen, 219324
Prevention and treatment of the post‐thrombotic syndrome
ISTH Academy, Arina Ten Cate-Hoek, 219325
Proteolytic processing of platelet receptors
ISTH Academy, Elizabeth Gardiner, 219326
Galectin‐3 in venous thrombosis: A possible new target for improved patient care
ISTH Academy, Jose Antonio Diaz, 219327
The coagulation system in atherothrombosis: Implications for new therapeutic strategies
ISTH Academy, Renske Olie, 219328
Product type and other environmental risk factors for inhibitor development in severe hemophilia A
ISTH Academy, Flora Peyvandi, 219329
Effects of daily aspirin on cancer incidence and mortality in the elderly Japanese
ISTH Academy, Kenji Yokoyama, 219339
Characteristics of pain, other symptoms and function in pediatric post‐thrombotic syndrome
ISTH Academy, Leonardo Brandao, 219340
Search engine optimization: What is it and why should we care?
ISTH Academy, Session Speakers, 219341
Update on the electrolytic IVC model for pre‐clinical studies of venous thrombosis
ISTH Academy, Jose Antonio Diaz, 219342
Antigenic binding sites of anti‐protein S autoantibodies in patients with recurrent pregnancy loss
ISTH Academy, Toshitaka Sugi, 219343
Current and future burden of venous thrombosis: Not simply predictable
ISTH Academy, Suzanne Cannegieter, 219344

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings